Breast Cancer Res Treat. 2010;121(1):101-110.Loehberg CR, Jud SM, Haeberle L et al. Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial. Breast Cancer Res Treat 2010; 121(1): 101-110....
The Development of an Assessment Model for the Risk of Breast Cancer: Comparison with Gail and Ibis ModelsCelikkanat, SirinGungormus, ZeynepKul, SevalInternational Journal of Caring Sciences
assessmentSoftwarevalidationStatisticalmodelsBackground Several approaches have been suggested for incorporating risk factors to predict the future risk of breast cancer. The Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) and International Breast Cancer Intervention ...
Risk AssessmentBACKGROUND: Initial results from the first International Breast Cancer Intervention Study (IBIS-I) found that tamoxifen reduced the risk of invasive estrogen receptor (ER)-positive tumors by 31% in women at increased risk for breast cancer, but most of...
Interpretation These findings show little or no impairment of cognitive performance with the use of anastrozole compared with placebo in postmenopausal women at high risk of developing breast cancer who were able to tolerate endocrine-related side-effects. Future studies assessing cognition should be ...